Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Armata Pharmaceuticals, Inc.

ARMP

Valuace

100

Růst

Zdraví

Cena

$ 10.49

+0.02 (0.31%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total Revenues	4.9	4.9	5.2	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.4	0.3	0.7
Cost of Revenues	1.5	1.5	34.4	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	3.4	3.4	-29.3	-29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.4	0.3	0.7

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	1.1	1.2	2.2	0.5	1.2	3.0	0.0	1.0	1.5	1.2
Cost of Revenues	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.2
Gross Profit	0.7	0.8	1.8	0.1	0.9	2.7	-0.3	0.6	1.2	1.0

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
R&D Expenses	0.0	0.0	0.0	33.8	35.0	20.0	14.4	9.8	4.9	2.9	5.7	4.0	5.8	6.5	1.5
Selling General & Admin Expenses	0.0	0.0	0.0	11.6	7.4	8.3	8.0	9.3	5.7	7.6	8.4	6.7	8.7	8.8	3.2
Depreciation & Amortization	1.5	1.5	1.3	1.0	0.9	1.2	1.1	1.6	0.4	0.4	0.4	0.3	0.2	0.1	0.1
Total Operating Expenses	34.6	34.6	13.2	11.6	36.9	23.8	21.6	19.1	10.6	10.5	14.1	10.7	14.5	15.3	4.7
Operating Income	-31.2	-31.2	-42.4	-40.9	-36.9	-23.8	-21.6	-19.8	-12.5	-16.2	-23.4	-10.2	-14.1	-15.0	-4.0

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.0
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.6
Depreciation & Amortization	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.2
Total Operating Expenses	9.1	8.6	8.6	8.3	11.4	12.4	11.6	10.9	10.8	10.3
Operating Income	-8.4	-7.8	-6.8	-8.2	-10.5	-9.8	-11.9	-10.2	-9.6	-10.3

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Income	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	16.6	16.6	10.7	2.6	0.0	0.1	0.6	0.9	0.0	0.0	0.0	0.0	0.0	2.9	0.3
Other Expense	-142.6	-142.6	23.5	-28.2	0.0	0.7	-0.6	0.3	-1.8	-3.8	-5.6	9.6	37.2	-40.6	0.1
IBT	-173.8	-173.8	-18.9	-69.0	-36.9	-23.2	-22.2	-19.5	-12.4	-14.1	-19.4	-0.6	23.1	-58.4	-4.3
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.1	0.6	-0.5	-0.3	-1.3	-0.6	-0.1	-37.2	43.4	-3.2
Net Income	-173.8	-173.8	-18.9	-69.0	-36.9	-23.2	-22.8	-19.0	-12.1	-12.8	-18.8	-0.5	23.1	-58.4	-1.1

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0
Interest Expense	4.8	4.3	3.8	3.6	3.3	2.9	2.7	1.8	1.5	1.2
Other Expense	-115.9	-18.9	-9.5	1.7	13.1	4.3	20.9	-14.8	-10.3	-20.8
IBT	-124.3	-26.7	-16.3	-6.5	2.6	-5.5	9.0	-25.0	-19.8	-31.2
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	-14.7
Net Income	-124.3	-26.7	-16.3	-6.5	2.6	-5.5	9.0	-25.0	-19.8	-31.2

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
EPS	$0.00	$0.00	$0.00	$-1.91	$-1.08	$-0.96	$-1.39	$-2.84	$-8.93	$-28.14	$-268.06	$-13.35	$589.40	$-4,040.33	$-161.76
EPS Diluted	$0.00	$0.00	$0.00	$-1.91	$-1.08	$-0.96	$-1.39	$-2.38	$-8.90	$-27.34	$-268.06	$-13.35	$-326.20	$-4,040.33	$-161.76
Shares Outstanding	36.2	36.2	36.2	36.1	34.3	24.1	16.4	6.7	1.4	0.5	0.1	0.0	0.0	0.0	0.0
Diluted Shares Outstanding	36.2	36.2	36.2	36.1	34.3	24.1	16.4	8.0	1.4	0.5	0.1	0.0	0.0	0.0	0.0

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.55	$-0.86
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.55	$-0.86
Shares Outstanding	36.2	36.2	36.2	36.2	36.2	36.2	36.2	36.1	36.1	36.1
Diluted Shares Outstanding	36.2	36.2	36.2	36.2	59.1	36.2	58.2	36.1	36.1	36.1

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash And Equivalents	26.4	9.3	13.5	14.9	10.3	9.6	6.0	8.2	5.1	5.7	9.4	6.6	20.4	0.9
Short Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	26.4	9.3	13.5	14.9	10.3	9.6	6.0	8.2	5.1	5.7	9.4	6.6	20.4	0.9
Accounts Receivable	1.2	0.7	3.4	1.9	3.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.6
Inventory	0.0	0.0	0.0	0.0	-3.0	-0.6	0.0	0.0	0.0	-0.6	0.0	0.0	0.0	0.0
Other Current Assets	3.3	1.3	2.3	10.3	4.7	1.2	0.6	0.3	0.3	0.6	0.5	0.3	0.2	0.1
Total Current Assets	30.9	11.3	19.2	27.0	15.0	10.8	6.7	8.4	5.4	6.4	10.0	7.0	20.5	1.7

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	14.8	4.3	11.7	9.3	17.1	26.4	37.9	13.5	24.0	12.5
Short Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	14.8	4.3	11.7	9.3	17.1	26.4	37.9	13.5	24.0	12.5
Accounts Receivable	0.8	2.2	0.2	0.7	2.2	1.2	1.7	3.4	8.5	8.6
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	-1.7	0.0	0.0	0.0
Other Current Assets	1.4	1.0	1.2	1.3	3.0	3.3	3.9	2.3	4.1	5.7
Total Current Assets	16.9	7.5	13.2	11.3	22.4	30.9	41.7	19.2	36.6	26.8

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Property, Plant & Equipment	57.1	54.9	57.3	46.7	38.1	12.8	4.2	0.5	0.8	1.1	1.1	1.2	0.1	0.1
Goodwill	3.5	3.5	3.5	3.5	3.5	3.5	3.5	0.0	0.0	0.0	7.6	7.6	4.3	7.4
Intangible Assets	10.3	10.3	10.3	10.3	10.3	10.3	10.3	3.0	4.9	10.8	12.8	12.8	12.9	12.9
Long-Term Investments	5.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	-9.2	1.0	8.2	8.4	3.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Long-Term Assets	77.4	75.1	79.2	68.8	54.8	28.7	18.8	3.5	5.8	11.8	21.5	21.6	17.4	20.4
Total Assets	108.3	86.4	98.4	95.8	69.8	39.5	25.5	11.9	11.1	18.2	31.5	28.6	37.9	22.1

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	52.5	53.2	54.0	54.9	55.9	57.1	56.9	57.3	54.1	52.5
Goodwill	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5
Intangible Assets	0.0	10.3	10.3	10.3	10.3	10.3	10.3	10.3	10.3	10.3
Long-Term Investments	0.0	0.0	5.4	5.5	0.0	5.5	5.5	5.7	5.8	5.7
Other Long-Term Assets	16.6	6.4	1.0	1.0	6.2	1.0	2.5	2.5	8.3	8.2
Total Long-Term Assets	72.6	73.3	74.1	75.1	75.8	77.4	78.6	90.8	76.2	74.4
Total Assets	89.5	80.8	87.3	86.4	98.2	108.3	120.4	110.0	112.8	101.2

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Accounts Payable	1.7	0.8	1.6	1.7	1.1	1.0	0.5	0.7	0.6	1.7	1.5	0.0	2.1	1.9
Short-Term Debt	118.0	43.4	19.0	17.0	1.5	2.3	1.3	0.0	0.0	0.8	0.0	0.0	0.0	3.6
Other Current Liabilities	3.5	4.1	-4.1	6.2	2.2	3.5	3.0	1.8	1.4	0.2	0.7	1.6	0.0	0.5
Current Liabilities	123.2	48.2	16.5	24.9	4.8	6.7	4.9	2.6	2.0	3.6	2.4	1.9	2.1	6.1

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.0	1.0	1.0	0.8	1.8	1.7	2.1	1.6	3.8	9.6
Short-Term Debt	87.5	116.8	107.2	43.4	112.4	118.0	104.2	19.0	13.4	40.9
Other Current Liabilities	52.4	2.3	2.3	4.1	4.0	3.5	3.8	-4.1	4.7	1.1
Current Liabilities	140.0	120.1	110.5	48.2	118.2	123.2	110.0	16.5	21.9	51.6

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Long-Term Debt	28.2	83.1	110.9	31.8	36.5	10.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases	28.2	32.1	38.1	48.8	38.0	12.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	3.1	3.1	3.1	3.1	3.1	3.1	3.1	0.8	1.1	2.4	3.0	3.1	0.0	3.1
Total Liabilities	154.4	134.5	130.4	59.8	44.4	20.7	10.9	3.4	3.4	8.5	18.8	25.2	52.2	9.1

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	26.8	27.1	27.4	83.1	27.9	28.2	63.7	110.9	100.2	27.4
Capital Leases	31.4	31.6	31.9	32.1	32.9	34.8	28.4	28.6	41.6	42.0
Def. Tax Liability	3.1	3.1	3.1	3.1	3.1	3.1	3.1	14.7	3.1	3.1
Total Liabilities	185.1	150.3	141.0	134.5	149.2	154.4	176.9	142.0	125.1	82.1

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Common Stock	0.4	0.4	0.4	0.4	0.3	0.2	0.1	0.3	0.1	0.2	0.1	2.0	1.8	0.7
Retained Earnings	-324.9	-327.7	-308.8	-239.8	-202.9	-179.7	-157.5	-406.3	-394.2	-381.4	-362.5	-362.0	-387.2	-320.5
Comprehensive Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-11.1	-18.2	-1.5	-12.3	-0.1	0.0
Total Common Equity	-46.1	-48.0	-32.1	36.1	25.4	18.9	14.6	8.5	7.7	9.7	12.7	3.4	-14.2	12.9

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
Retained Earnings	-377.2	-350.6	-334.3	-327.7	-330.3	-324.9	-333.8	-308.8	-289.0	-257.8
Comprehensive Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Common Equity	-95.6	-69.5	-53.8	-48.0	-51.0	-46.1	-56.5	-32.1	-12.4	19.1

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total Debt		146.1	126.5	120.4	48.8	38.0	13.2	2.9	0.0	0.0	0.8	0.0	0.0	0.0	3.6
Book Value		-46.1	-48.0	-32.1	36.1	25.4	18.9	14.6	8.5	7.7	9.7	12.7	3.4	-14.2	12.9

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		-95.6	-69.5	-53.8	-48.0	-51.0	-46.1	-56.5	-32.1	-12.4	19.1

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income	-67.0	-173.8	-18.9	-69.0	-36.9	-23.2	-22.2	-19.5	-12.1	-12.8	-18.8	-0.5	23.1	-58.4	-4.3
Depreciation & Amortization	1.1	1.5	1.3	1.0	0.9	1.2	1.1	1.4	0.4	0.4	0.4	0.3	0.2	0.1	0.1
Stock-Based Compensation	1.7	2.6	2.9	0.9	3.1	2.9	3.5	4.3	0.5	0.7	2.0	0.5	1.9	1.4	0.0
Change Working Capital	-1.7	-1.4	-2.1	-9.6	0.4	-3.2	-0.9	-2.2	0.3	-0.5	0.7	-0.2	-0.6	1.1	-0.2
Change In Accounts Receivable	-0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	-0.1	0.0	0.1
Change In Accounts Payable	-2.2	-0.3	-3.8	0.0	3.7	0.2	0.5	-1.4	0.3	-0.8	0.3	0.3	-1.0	0.2	-0.5
Change In Inventories	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0
Other Non-cash Items	29.2	145.3	-20.8	29.4	0.0	0.1	0.6	0.9	1.8	4.3	5.8	-9.8	-37.2	5.2	0.0
Cash from Operations	-38.6	0.0	0.0	-47.4	-32.5	-23.6	-18.3	-15.6	-9.4	-9.2	-10.6	-9.8	-12.6	-7.4	-4.3

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-124.3	-26.7	-16.3	-6.5	2.6	-5.5	9.0	-25.0	-19.8	-31.2
Depreciation & Amortization	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.2
Stock-Based Compensation	0.6	0.6	0.6	0.8	0.4	0.7	1.3	0.0	0.2	-0.4
Change Working Capital	0.0	1.8	-2.0	-1.2	1.2	-1.0	-0.7	-1.7	0.6	0.1
Change In Accounts Receivable	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.7	0.0
Change In Accounts Payable	-0.3	0.8	-0.3	-0.6	-1.7	0.0	-0.7	-1.5	0.4	-0.4
Change In Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0
Other Non-cash Items	116.6	19.6	10.1	-1.0	-12.5	-3.3	-20.2	15.8	11.1	17.7
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.1	-9.7

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2017	2016	2015	2014	2013	2012
Capital Expenditure	-7.5	-0.5	-1.9	-8.1	-2.2	-1.3	-0.8	-0.1	-0.1	-0.3	-0.2	-1.2	-0.1	-0.1
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2
Cash from Investing	-7.5	0.0	0.0	-8.1	-2.2	-1.3	-0.8	2.9	-0.1	-0.3	-0.2	-1.2	-0.1	3.1

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.1	-0.2	-0.1	-0.1	0.1	-0.3	-1.4	-0.3	-2.4	-3.5
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2.4	-3.5

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Debt Repaid	-104.7	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	-0.8	-0.1	0.0	0.0	0.0
Debt Issued	224.5	126.5	6.1	125.6	10.8	24.8	10.3	2.9	0.0	0.0	0.9	0.0	-3.6	3.6
Issuance of Common Stock	0.1	0.0	0.0	0.0	44.4	26.3	22.9	10.0	12.2	9.4	7.6	12.4	18.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.2	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	0.0	0.0	0.0
Other Financing Activities	24.8	0.0	0.0	0.0	-0.4	-0.8	0.3	-1.0	0.2	0.1	0.0	0.4	9.0	1.0
Cash from Financing	59.8	0.0	0.0	54.0	44.0	25.5	23.2	9.0	12.5	8.7	7.2	12.8	27.0	1.0

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8
Debt Issued	114.4	-29.6	9.3	8.1	-13.8	-5.8	-21.8	47.5	6.7	112.1
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Change in Cash		14.1	-0.7	-4.5	-1.6	9.3	0.6	4.1	-3.7	3.0	-0.6	-3.7	2.8	-13.8	19.5	-0.2
Closing Cash Balance		26.4	14.1	14.8	19.2	20.8	11.5	10.8	6.7	8.2	5.1	5.7	9.4	6.6	20.4	0.9

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-6.1	10.4	-7.4	2.3	-7.9	-9.3	-11.5	24.3	-10.4	11.6
Closing Cash Balance		14.1	14.8	9.7	17.1	14.8	22.6	26.4	37.9	13.5	29.8

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Free Cash Flow		-46.1	-26.3	-39.4	-55.6	-34.7	-24.9	-19.1	-15.7	-9.4	-9.3	-10.9	-10.0	-13.8	-7.6	-4.3
Real Free Cash Flow		-47.8	-28.9	-42.3	-56.5	-37.8	-27.8	-22.6	-20.0	-9.9	-10.0	-12.9	-10.5	-15.7	-9.0	-4.3

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-6.7	-4.5	-7.4	-7.7	-7.9	-9.2	-11.5	-10.8	-10.5	-13.2
Real Free Cash Flow		-7.4	-5.2	-7.9	-8.5	-8.2	-9.9	-12.9	-10.8	-10.7	-12.8